Cross Country Healthcare Inc

Most Recent

  • uploads///family _
    Company & Industry Overviews

    What Analysts Recommend for Amedisys and Peers in March 2018

    Of the 11 analysts covering Amedisys in March 2018, three analysts have given the stock a “strong buy” rating.

    By Kenneth Smith
  • uploads///ambulance __
    Company & Industry Overviews

    Analyst Ratings for BioTelemetry and Its Peers in March 2018

    Of the seven analysts covering BioTelemetry in March 2018, two have given it a “strong buy” rating, and five have given it a “buy.”

    By Kenneth Smith
  • uploads///BEAT
    Company & Industry Overviews

    Understanding BioTelemetry’s Business Strategy

    BioTelemetry’s (BEAT) business strategy is to solidify its position as a leading provider of outpatient cardiac monitoring services.

    By Kenneth Smith
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.